Wedge Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.7M Buy
109,674
+1,842
+2% +$484K 0.51% 81
2026
Q1
$28.8M Sell
107,832
-2,843
-3% -$770K 0.53% 80
2025
Q4
$27.8M Buy
110,675
+14,892
+16% +$3.96M 0.5% 87
2025
Q3
$27.5M Sell
95,783
-22,859
-19% -$6.12M 0.47% 81
2025
Q2
$31.1M Sell
118,642
-19,418
-14% -$4.73M 0.56% 75
2025
Q1
$32.1M Buy
138,060
+12,960
+10% +$3.14M 0.62% 78
2024
Q4
$28.7M Sell
125,100
-17,868
-12% -$4.1M 0.52% 70
2024
Q3
$32M Sell
142,968
-28,488
-17% -$6.26M 0.55% 73
2024
Q2
$34.9M Sell
171,456
-3,464
-2% -$705K 0.62% 66
2024
Q1
$38.2M Buy
174,920
+32,679
+23% +$7.2M 0.62% 71
2023
Q4
$32.3M Sell
142,241
-6,627
-4% -$1.39M 0.58% 56
2023
Q3
$29.9M Sell
148,868
-15,112
-9% -$3.19M 0.59% 68
2023
Q2
$34M Sell
163,980
-29,388
-15% -$5.7M 0.54% 38
2023
Q1
$38.1M Buy
193,368
+3,138
+2% +$646K 0.64% 32
2022
Q4
$38.5M Buy
190,230
+4,418
+2% +$863K 0.62% 42
2022
Q3
$32.7M Buy
185,812
+13,513
+8% +$2.77M 0.55% 74
2022
Q2
$34.7M Buy
172,299
+35,033
+26% +$7.47M 0.55% 66
2022
Q1
$31.1M Buy
137,266
+9,633
+8% +$2.27M 0.42% 115
2021
Q4
$34.5M Buy
127,633
+4,584
+4% +$1.13M 0.43% 95
2021
Q3
$29.8M Sell
123,049
-12,850
-9% -$3.24M 0.38% 99
2021
Q2
$32.2M Sell
135,899
-15,336
-10% -$3.49M 0.39% 81
2021
Q1
$33.1M Sell
151,235
-3,404
-2% -$683K 0.39% 93
2020
Q4
$27M Sell
154,639
-17,809
-10% -$3.08M 0.31% 123
2020
Q3
$27.9M Buy
+172,448
New +$27.3M 0.37% 78
2020
Q2
Sell
-285,747
Closed -$31M 538
2020
Q1
$31M Buy
285,747
+1,631
+0.6% +$235K 0.54% 75
2019
Q4
$41.3M Buy
284,116
+55,253
+24% +$7.98M 0.46% 82
2019
Q3
$33M Sell
228,863
-922
-0.4% -$135K 0.38% 101
2019
Q2
$34.1M Buy
+229,785
New +$32.1M 0.39% 91
2015
Q4
Sell
-379,243
Closed -$35.3M 604
2015
Q3
$35.3M Sell
379,243
-38,499
-9% -$3.98M 0.37% 87
2015
Q2
$43.5M Sell
417,742
-81,888
-16% -$8.52M 0.42% 78
2015
Q1
$54.1M Buy
499,630
+491,482
+6,032% +$50.5M 0.54% 46
2014
Q4
$755K Sell
8,148
-146
-2% -$12.9K 0.01% 367
2014
Q3
$725K Buy
8,294
+582
+8% +$52.6K 0.01% 372
2014
Q2
$678K Buy
7,712
+3,376
+78% +$292K 0.01% 370
2014
Q1
$366K Sell
4,336
-204
-4% -$16.3K ﹤0.01% 400
2013
Q4
$356K Buy
+4,540
New +$387K ﹤0.01% 399

Other funds holding LH

Wedge Capital Management's LH Position: Q2 2026 in Review

Wedge Capital Management increased its Labcorp (LH) stake by 1.7% in Q2 2026, buying an estimated $484K and bringing the position to 109,674 shares worth $30.7M. The position accounts for 0.51% of the portfolio, ranked #81.

Wedge Capital Management first reported a position in LH in Q4 2013 and has held it in 36 quarters since. The position peaked at $54.1M in Q1 2015. 147 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Wedge Capital Management held 109,674 shares of Labcorp worth $30.7M as of Q2 2026.
  • Wedge Capital Management bought 1,842 Labcorp shares in Q2 2026, an estimated $484K.
  • Labcorp made up 0.51% of Wedge Capital Management's portfolio in Q2 2026, its #81 holding.
  • Wedge Capital Management first reported a position in Labcorp in Q4 2013 and has held it in 36 quarters since.
  • Wedge Capital Management's Labcorp position peaked at $54.1M in Q1 2015.
  • 147 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.